|
1.27
|
7.16e-80
|
GO:0044237
|
cellular metabolic process
|
|
1.24
|
2.73e-77
|
GO:0008152
|
metabolic process
|
|
1.26
|
2.48e-72
|
GO:0044238
|
primary metabolic process
|
|
1.31
|
1.57e-57
|
GO:0019222
|
regulation of metabolic process
|
|
1.28
|
1.04e-55
|
GO:0044260
|
cellular macromolecule metabolic process
|
|
1.32
|
3.92e-52
|
GO:0031323
|
regulation of cellular metabolic process
|
|
1.32
|
8.33e-52
|
GO:0006807
|
nitrogen compound metabolic process
|
|
1.25
|
3.70e-51
|
GO:0043170
|
macromolecule metabolic process
|
|
1.32
|
1.93e-50
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
|
1.31
|
4.41e-49
|
GO:0080090
|
regulation of primary metabolic process
|
|
1.33
|
1.47e-47
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.32
|
2.83e-47
|
GO:0060255
|
regulation of macromolecule metabolic process
|
|
1.36
|
1.94e-46
|
GO:0010468
|
regulation of gene expression
|
|
1.34
|
2.36e-45
|
GO:0071840
|
cellular component organization or biogenesis
|
|
1.34
|
4.29e-45
|
GO:0016043
|
cellular component organization
|
|
1.37
|
6.74e-45
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
|
1.35
|
1.18e-44
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.35
|
6.18e-44
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
|
1.32
|
1.94e-43
|
GO:0009058
|
biosynthetic process
|
|
1.32
|
3.36e-43
|
GO:0044249
|
cellular biosynthetic process
|
|
1.35
|
1.14e-42
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
|
1.34
|
6.74e-42
|
GO:0031326
|
regulation of cellular biosynthetic process
|
|
1.37
|
8.62e-42
|
GO:0051252
|
regulation of RNA metabolic process
|
|
1.33
|
2.51e-41
|
GO:0009889
|
regulation of biosynthetic process
|
|
1.38
|
3.00e-40
|
GO:0048523
|
negative regulation of cellular process
|
|
1.36
|
2.32e-39
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
|
1.32
|
7.61e-39
|
GO:0048518
|
positive regulation of biological process
|
|
1.30
|
2.35e-38
|
GO:0032502
|
developmental process
|
|
1.35
|
3.89e-38
|
GO:0048519
|
negative regulation of biological process
|
|
1.34
|
1.42e-37
|
GO:0048522
|
positive regulation of cellular process
|
|
1.30
|
1.26e-35
|
GO:0007275
|
multicellular organismal development
|
|
1.31
|
6.09e-35
|
GO:0090304
|
nucleic acid metabolic process
|
|
1.34
|
1.23e-33
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
|
1.35
|
5.74e-33
|
GO:0071842
|
cellular component organization at cellular level
|
|
1.32
|
1.28e-31
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
|
1.30
|
1.76e-31
|
GO:0048856
|
anatomical structure development
|
|
1.32
|
2.41e-31
|
GO:0009059
|
macromolecule biosynthetic process
|
|
1.26
|
2.06e-29
|
GO:0051179
|
localization
|
|
1.30
|
5.64e-28
|
GO:0048731
|
system development
|
|
1.30
|
1.90e-27
|
GO:0016070
|
RNA metabolic process
|
|
1.35
|
8.87e-27
|
GO:0006351
|
transcription, DNA-dependent
|
|
1.35
|
1.07e-26
|
GO:0032774
|
RNA biosynthetic process
|
|
1.09
|
1.21e-25
|
GO:0009987
|
cellular process
|
|
1.38
|
2.88e-25
|
GO:0006996
|
organelle organization
|
|
1.27
|
9.21e-25
|
GO:0010467
|
gene expression
|
|
1.44
|
1.45e-24
|
GO:0009892
|
negative regulation of metabolic process
|
|
1.45
|
1.19e-23
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
|
1.45
|
1.35e-23
|
GO:0031324
|
negative regulation of cellular metabolic process
|
|
1.31
|
1.96e-23
|
GO:0030154
|
cell differentiation
|
|
1.30
|
9.32e-23
|
GO:0048869
|
cellular developmental process
|
|
1.25
|
2.94e-22
|
GO:0051234
|
establishment of localization
|
|
1.26
|
3.64e-22
|
GO:0006810
|
transport
|
|
1.37
|
7.93e-22
|
GO:0009653
|
anatomical structure morphogenesis
|
|
1.38
|
1.17e-21
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
|
1.35
|
2.25e-21
|
GO:0023051
|
regulation of signaling
|
|
1.39
|
4.34e-21
|
GO:0009966
|
regulation of signal transduction
|
|
1.33
|
9.30e-21
|
GO:0048583
|
regulation of response to stimulus
|
|
1.35
|
1.13e-20
|
GO:0009893
|
positive regulation of metabolic process
|
|
1.32
|
4.32e-20
|
GO:0044281
|
small molecule metabolic process
|
|
1.42
|
8.48e-20
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
|
1.32
|
1.03e-19
|
GO:0006464
|
protein modification process
|
|
1.49
|
1.14e-19
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
|
1.47
|
1.70e-19
|
GO:0009890
|
negative regulation of biosynthetic process
|
|
1.35
|
2.85e-19
|
GO:0031325
|
positive regulation of cellular metabolic process
|
|
1.30
|
3.82e-19
|
GO:0043412
|
macromolecule modification
|
|
1.47
|
4.08e-19
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
|
1.50
|
4.88e-19
|
GO:0010629
|
negative regulation of gene expression
|
|
1.49
|
7.74e-19
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
|
1.44
|
1.51e-18
|
GO:0010628
|
positive regulation of gene expression
|
|
1.30
|
1.86e-18
|
GO:0048513
|
organ development
|
|
1.32
|
6.85e-18
|
GO:0065009
|
regulation of molecular function
|
|
1.36
|
8.25e-18
|
GO:0007399
|
nervous system development
|
|
1.26
|
8.45e-18
|
GO:0044267
|
cellular protein metabolic process
|
|
1.36
|
1.09e-17
|
GO:0033036
|
macromolecule localization
|
|
1.49
|
7.36e-17
|
GO:0051253
|
negative regulation of RNA metabolic process
|
|
1.38
|
9.43e-17
|
GO:0051641
|
cellular localization
|
|
1.41
|
1.37e-16
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.49
|
1.39e-16
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
|
1.46
|
1.48e-16
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
|
1.41
|
1.77e-16
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
|
1.46
|
1.99e-16
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.44
|
2.81e-16
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
|
1.43
|
2.81e-16
|
GO:0051254
|
positive regulation of RNA metabolic process
|
|
1.42
|
6.02e-16
|
GO:0009790
|
embryo development
|
|
1.37
|
9.29e-16
|
GO:0050793
|
regulation of developmental process
|
|
1.37
|
1.10e-15
|
GO:0008104
|
protein localization
|
|
1.41
|
1.22e-15
|
GO:0051128
|
regulation of cellular component organization
|
|
1.39
|
1.25e-15
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
|
1.22
|
1.47e-15
|
GO:0019538
|
protein metabolic process
|
|
1.42
|
5.16e-15
|
GO:0045595
|
regulation of cell differentiation
|
|
1.37
|
8.14e-15
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
|
1.37
|
1.45e-14
|
GO:0009891
|
positive regulation of biosynthetic process
|
|
1.53
|
3.44e-14
|
GO:0051726
|
regulation of cell cycle
|
|
1.46
|
4.68e-14
|
GO:0046907
|
intracellular transport
|
|
1.32
|
4.74e-14
|
GO:0009056
|
catabolic process
|
|
1.50
|
4.97e-14
|
GO:0072358
|
cardiovascular system development
|
|
1.50
|
4.97e-14
|
GO:0072359
|
circulatory system development
|
|
1.29
|
8.56e-14
|
GO:0051239
|
regulation of multicellular organismal process
|
|
1.34
|
9.06e-14
|
GO:0010646
|
regulation of cell communication
|
|
1.50
|
9.31e-14
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
|
1.36
|
2.72e-13
|
GO:0042127
|
regulation of cell proliferation
|
|
1.32
|
2.97e-13
|
GO:0050790
|
regulation of catalytic activity
|
|
1.35
|
3.16e-13
|
GO:0032268
|
regulation of cellular protein metabolic process
|
|
1.49
|
7.89e-13
|
GO:0043009
|
chordate embryonic development
|
|
1.38
|
9.23e-13
|
GO:0045184
|
establishment of protein localization
|
|
1.34
|
9.24e-13
|
GO:0042981
|
regulation of apoptosis
|
|
1.33
|
1.38e-12
|
GO:0010941
|
regulation of cell death
|
|
1.34
|
1.45e-12
|
GO:0043067
|
regulation of programmed cell death
|
|
1.55
|
2.02e-12
|
GO:0009968
|
negative regulation of signal transduction
|
|
1.38
|
2.23e-12
|
GO:0015031
|
protein transport
|
|
1.36
|
2.62e-12
|
GO:0051649
|
establishment of localization in cell
|
|
1.36
|
2.99e-12
|
GO:0009888
|
tissue development
|
|
1.32
|
4.78e-12
|
GO:0035556
|
intracellular signal transduction
|
|
1.63
|
8.33e-12
|
GO:0007507
|
heart development
|
|
1.51
|
1.00e-11
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
|
1.32
|
1.06e-11
|
GO:0044248
|
cellular catabolic process
|
|
1.44
|
1.23e-11
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
|
1.52
|
1.54e-11
|
GO:0032583
|
regulation of gene-specific transcription
|
|
1.51
|
1.69e-11
|
GO:0010648
|
negative regulation of cell communication
|
|
1.50
|
2.58e-11
|
GO:0023057
|
negative regulation of signaling
|
|
1.35
|
2.80e-11
|
GO:2000026
|
regulation of multicellular organismal development
|
|
1.31
|
2.93e-11
|
GO:0051246
|
regulation of protein metabolic process
|
|
1.36
|
4.31e-11
|
GO:0007049
|
cell cycle
|
|
1.56
|
4.52e-11
|
GO:0035295
|
tube development
|
|
1.41
|
5.68e-11
|
GO:0009887
|
organ morphogenesis
|
|
1.31
|
1.09e-10
|
GO:0006793
|
phosphorus metabolic process
|
|
1.31
|
1.17e-10
|
GO:0006796
|
phosphate metabolic process
|
|
1.36
|
1.59e-10
|
GO:0048699
|
generation of neurons
|
|
1.49
|
2.71e-10
|
GO:0060284
|
regulation of cell development
|
|
1.34
|
3.78e-10
|
GO:0022008
|
neurogenesis
|
|
1.44
|
5.81e-10
|
GO:0048585
|
negative regulation of response to stimulus
|
|
1.56
|
6.19e-10
|
GO:0001701
|
in utero embryonic development
|
|
1.47
|
7.68e-10
|
GO:0040008
|
regulation of growth
|
|
1.22
|
8.20e-10
|
GO:0065008
|
regulation of biological quality
|
|
1.30
|
9.42e-10
|
GO:0044085
|
cellular component biogenesis
|
|
1.47
|
2.39e-09
|
GO:0060429
|
epithelium development
|
|
1.41
|
2.50e-09
|
GO:0051094
|
positive regulation of developmental process
|
|
1.52
|
2.53e-09
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
|
1.52
|
3.35e-09
|
GO:0016568
|
chromatin modification
|
|
1.42
|
4.23e-09
|
GO:0051276
|
chromosome organization
|
|
1.32
|
7.05e-09
|
GO:0048468
|
cell development
|
|
1.35
|
1.01e-08
|
GO:0016265
|
death
|
|
1.37
|
1.02e-08
|
GO:0016192
|
vesicle-mediated transport
|
|
1.37
|
1.08e-08
|
GO:0012501
|
programmed cell death
|
|
1.31
|
1.14e-08
|
GO:0022607
|
cellular component assembly
|
|
1.48
|
1.16e-08
|
GO:0048729
|
tissue morphogenesis
|
|
1.33
|
1.23e-08
|
GO:0044093
|
positive regulation of molecular function
|
|
1.47
|
1.55e-08
|
GO:0006325
|
chromatin organization
|
|
1.46
|
1.83e-08
|
GO:0045597
|
positive regulation of cell differentiation
|
|
1.36
|
2.09e-08
|
GO:0006915
|
apoptosis
|
|
1.28
|
2.53e-08
|
GO:0032879
|
regulation of localization
|
|
1.42
|
2.73e-08
|
GO:0070727
|
cellular macromolecule localization
|
|
1.34
|
2.97e-08
|
GO:0008219
|
cell death
|
|
1.52
|
3.27e-08
|
GO:0001568
|
blood vessel development
|
|
1.35
|
3.70e-08
|
GO:0033554
|
cellular response to stress
|
|
1.41
|
3.79e-08
|
GO:0006753
|
nucleoside phosphate metabolic process
|
|
1.41
|
3.79e-08
|
GO:0009117
|
nucleotide metabolic process
|
|
1.50
|
3.91e-08
|
GO:0001944
|
vasculature development
|
|
1.42
|
4.19e-08
|
GO:0034613
|
cellular protein localization
|
|
1.39
|
5.26e-08
|
GO:0055086
|
nucleobase, nucleoside and nucleotide metabolic process
|
|
1.36
|
7.13e-08
|
GO:0046483
|
heterocycle metabolic process
|
|
1.34
|
9.49e-08
|
GO:0019220
|
regulation of phosphate metabolic process
|
|
1.34
|
9.49e-08
|
GO:0051174
|
regulation of phosphorus metabolic process
|
|
1.46
|
1.12e-07
|
GO:0051960
|
regulation of nervous system development
|
|
1.55
|
1.14e-07
|
GO:0061061
|
muscle structure development
|
|
1.38
|
1.37e-07
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
|
1.48
|
1.56e-07
|
GO:0050767
|
regulation of neurogenesis
|
|
1.51
|
2.42e-07
|
GO:0002009
|
morphogenesis of an epithelium
|
|
1.34
|
2.74e-07
|
GO:0042325
|
regulation of phosphorylation
|
|
1.47
|
3.30e-07
|
GO:0006886
|
intracellular protein transport
|
|
1.30
|
3.51e-07
|
GO:0016310
|
phosphorylation
|
|
1.40
|
3.72e-07
|
GO:0043066
|
negative regulation of apoptosis
|
|
1.51
|
4.09e-07
|
GO:0007264
|
small GTPase mediated signal transduction
|
|
1.41
|
4.24e-07
|
GO:0048598
|
embryonic morphogenesis
|
|
1.31
|
5.01e-07
|
GO:0031399
|
regulation of protein modification process
|
|
1.38
|
7.77e-07
|
GO:0060548
|
negative regulation of cell death
|
|
1.38
|
7.81e-07
|
GO:0043068
|
positive regulation of programmed cell death
|
|
1.50
|
9.56e-07
|
GO:0045664
|
regulation of neuron differentiation
|
|
1.47
|
9.67e-07
|
GO:0051098
|
regulation of binding
|
|
1.45
|
1.06e-06
|
GO:0051130
|
positive regulation of cellular component organization
|
|
1.37
|
1.32e-06
|
GO:0010942
|
positive regulation of cell death
|
|
1.46
|
1.60e-06
|
GO:0032535
|
regulation of cellular component size
|
|
1.54
|
1.66e-06
|
GO:0043193
|
positive regulation of gene-specific transcription
|
|
1.36
|
1.79e-06
|
GO:0008284
|
positive regulation of cell proliferation
|
|
1.38
|
1.97e-06
|
GO:0043069
|
negative regulation of programmed cell death
|
|
1.34
|
2.50e-06
|
GO:0071844
|
cellular component assembly at cellular level
|
|
1.37
|
2.93e-06
|
GO:0043065
|
positive regulation of apoptosis
|
|
1.38
|
3.57e-06
|
GO:0007010
|
cytoskeleton organization
|
|
1.41
|
3.98e-06
|
GO:0090066
|
regulation of anatomical structure size
|
|
1.51
|
3.99e-06
|
GO:0051101
|
regulation of DNA binding
|
|
1.46
|
4.19e-06
|
GO:0009259
|
ribonucleotide metabolic process
|
|
1.44
|
4.78e-06
|
GO:0009894
|
regulation of catabolic process
|
|
1.58
|
4.83e-06
|
GO:0016569
|
covalent chromatin modification
|
|
1.52
|
5.03e-06
|
GO:0030029
|
actin filament-based process
|
|
1.32
|
5.42e-06
|
GO:0043085
|
positive regulation of catalytic activity
|
|
1.36
|
6.00e-06
|
GO:0044282
|
small molecule catabolic process
|
|
1.60
|
6.02e-06
|
GO:0060562
|
epithelial tube morphogenesis
|
|
1.53
|
6.57e-06
|
GO:0001558
|
regulation of cell growth
|
|
1.53
|
6.86e-06
|
GO:0030036
|
actin cytoskeleton organization
|
|
1.54
|
7.15e-06
|
GO:0030900
|
forebrain development
|
|
1.18
|
7.60e-06
|
GO:0042221
|
response to chemical stimulus
|
|
1.46
|
7.80e-06
|
GO:0009150
|
purine ribonucleotide metabolic process
|
|
1.38
|
7.94e-06
|
GO:0051247
|
positive regulation of protein metabolic process
|
|
1.58
|
7.96e-06
|
GO:0016570
|
histone modification
|
|
1.29
|
8.57e-06
|
GO:0051049
|
regulation of transport
|
|
1.58
|
8.73e-06
|
GO:0007346
|
regulation of mitotic cell cycle
|
|
1.42
|
1.31e-05
|
GO:0007420
|
brain development
|
|
1.42
|
1.39e-05
|
GO:0051301
|
cell division
|
|
1.58
|
1.40e-05
|
GO:0010552
|
positive regulation of gene-specific transcription from RNA polymerase II promoter
|
|
1.38
|
1.44e-05
|
GO:0032270
|
positive regulation of cellular protein metabolic process
|
|
1.46
|
1.45e-05
|
GO:0009141
|
nucleoside triphosphate metabolic process
|
|
1.49
|
1.75e-05
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
|
1.47
|
2.04e-05
|
GO:0009199
|
ribonucleoside triphosphate metabolic process
|
|
1.69
|
2.11e-05
|
GO:0003007
|
heart morphogenesis
|
|
1.52
|
2.53e-05
|
GO:0051090
|
regulation of sequence-specific DNA binding transcription factor activity
|
|
1.38
|
2.62e-05
|
GO:0072521
|
purine-containing compound metabolic process
|
|
1.50
|
2.91e-05
|
GO:0009143
|
nucleoside triphosphate catabolic process
|
|
1.49
|
3.09e-05
|
GO:0048514
|
blood vessel morphogenesis
|
|
1.31
|
3.17e-05
|
GO:0022402
|
cell cycle process
|
|
1.51
|
3.37e-05
|
GO:0090046
|
regulation of transcription regulator activity
|
|
1.69
|
3.57e-05
|
GO:0035107
|
appendage morphogenesis
|
|
1.69
|
3.57e-05
|
GO:0035108
|
limb morphogenesis
|
|
1.68
|
3.62e-05
|
GO:0048736
|
appendage development
|
|
1.68
|
3.62e-05
|
GO:0060173
|
limb development
|
|
1.45
|
3.76e-05
|
GO:0009144
|
purine nucleoside triphosphate metabolic process
|
|
1.31
|
3.88e-05
|
GO:0001932
|
regulation of protein phosphorylation
|
|
1.58
|
4.17e-05
|
GO:0016055
|
Wnt receptor signaling pathway
|
|
1.50
|
4.42e-05
|
GO:0035239
|
tube morphogenesis
|
|
1.46
|
4.47e-05
|
GO:0009205
|
purine ribonucleoside triphosphate metabolic process
|
|
1.85
|
4.83e-05
|
GO:0009953
|
dorsal/ventral pattern formation
|
|
1.73
|
5.49e-05
|
GO:0016331
|
morphogenesis of embryonic epithelium
|
|
1.34
|
7.17e-05
|
GO:0005975
|
carbohydrate metabolic process
|
|
1.47
|
7.47e-05
|
GO:0032269
|
negative regulation of cellular protein metabolic process
|
|
1.47
|
7.47e-05
|
GO:0072523
|
purine-containing compound catabolic process
|
|
1.59
|
7.75e-05
|
GO:0045786
|
negative regulation of cell cycle
|
|
1.45
|
7.85e-05
|
GO:0051248
|
negative regulation of protein metabolic process
|
|
1.47
|
7.90e-05
|
GO:0008361
|
regulation of cell size
|
|
1.47
|
8.83e-05
|
GO:0006195
|
purine nucleotide catabolic process
|
|
1.39
|
9.10e-05
|
GO:0006163
|
purine nucleotide metabolic process
|
|
1.61
|
9.17e-05
|
GO:0060541
|
respiratory system development
|
|
1.36
|
9.59e-05
|
GO:0061024
|
membrane organization
|
|
1.49
|
1.01e-04
|
GO:0051129
|
negative regulation of cellular component organization
|
|
1.65
|
1.02e-04
|
GO:0030111
|
regulation of Wnt receptor signaling pathway
|
|
1.49
|
1.07e-04
|
GO:0009146
|
purine nucleoside triphosphate catabolic process
|
|
1.49
|
1.12e-04
|
GO:0009203
|
ribonucleoside triphosphate catabolic process
|
|
1.44
|
1.26e-04
|
GO:0031329
|
regulation of cellular catabolic process
|
|
1.51
|
1.28e-04
|
GO:0031344
|
regulation of cell projection organization
|
|
1.51
|
1.28e-04
|
GO:0032582
|
negative regulation of gene-specific transcription
|
|
1.25
|
1.42e-04
|
GO:0006629
|
lipid metabolic process
|
|
1.33
|
1.44e-04
|
GO:0006259
|
DNA metabolic process
|
|
1.41
|
1.50e-04
|
GO:0045596
|
negative regulation of cell differentiation
|
|
1.27
|
1.60e-04
|
GO:0006468
|
protein phosphorylation
|
|
1.71
|
1.66e-04
|
GO:0030326
|
embryonic limb morphogenesis
|
|
1.71
|
1.66e-04
|
GO:0035113
|
embryonic appendage morphogenesis
|
|
1.48
|
1.70e-04
|
GO:0009207
|
purine ribonucleoside triphosphate catabolic process
|
|
1.35
|
1.81e-04
|
GO:0016044
|
cellular membrane organization
|
|
1.44
|
1.84e-04
|
GO:0009166
|
nucleotide catabolic process
|
|
1.80
|
1.93e-04
|
GO:0030178
|
negative regulation of Wnt receptor signaling pathway
|
|
1.38
|
2.05e-04
|
GO:0008285
|
negative regulation of cell proliferation
|
|
1.41
|
2.28e-04
|
GO:0000904
|
cell morphogenesis involved in differentiation
|
|
1.60
|
2.37e-04
|
GO:0051169
|
nuclear transport
|
|
1.33
|
2.48e-04
|
GO:0032989
|
cellular component morphogenesis
|
|
1.36
|
2.65e-04
|
GO:0051093
|
negative regulation of developmental process
|
|
1.25
|
2.71e-04
|
GO:0048584
|
positive regulation of response to stimulus
|
|
1.40
|
3.25e-04
|
GO:0044270
|
cellular nitrogen compound catabolic process
|
|
1.33
|
3.28e-04
|
GO:0044283
|
small molecule biosynthetic process
|
|
1.32
|
3.57e-04
|
GO:0071310
|
cellular response to organic substance
|
|
1.34
|
3.88e-04
|
GO:0000902
|
cell morphogenesis
|
|
1.59
|
3.93e-04
|
GO:0006913
|
nucleocytoplasmic transport
|
|
1.46
|
4.06e-04
|
GO:0009261
|
ribonucleotide catabolic process
|
|
1.34
|
4.12e-04
|
GO:0009719
|
response to endogenous stimulus
|
|
1.42
|
4.37e-04
|
GO:0001501
|
skeletal system development
|
|
1.62
|
4.52e-04
|
GO:0030323
|
respiratory tube development
|
|
1.46
|
4.55e-04
|
GO:0009154
|
purine ribonucleotide catabolic process
|
|
1.40
|
4.76e-04
|
GO:0033043
|
regulation of organelle organization
|
|
1.36
|
4.78e-04
|
GO:0007389
|
pattern specification process
|
|
1.56
|
4.85e-04
|
GO:0048705
|
skeletal system morphogenesis
|
|
1.40
|
5.24e-04
|
GO:0046700
|
heterocycle catabolic process
|
|
1.33
|
5.42e-04
|
GO:0007417
|
central nervous system development
|
|
1.36
|
5.46e-04
|
GO:0044262
|
cellular carbohydrate metabolic process
|
|
1.53
|
5.49e-04
|
GO:0010975
|
regulation of neuron projection development
|
|
1.41
|
5.77e-04
|
GO:0034655
|
nucleobase, nucleoside, nucleotide and nucleic acid catabolic process
|
|
1.41
|
5.77e-04
|
GO:0034656
|
nucleobase, nucleoside and nucleotide catabolic process
|
|
1.36
|
5.90e-04
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
|
1.41
|
6.55e-04
|
GO:0018193
|
peptidyl-amino acid modification
|
|
1.74
|
7.49e-04
|
GO:0010563
|
negative regulation of phosphorus metabolic process
|
|
1.74
|
7.49e-04
|
GO:0045936
|
negative regulation of phosphate metabolic process
|
|
1.33
|
7.60e-04
|
GO:0022403
|
cell cycle phase
|
|
1.30
|
8.19e-04
|
GO:0023056
|
positive regulation of signaling
|
|
1.37
|
8.22e-04
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
|
1.50
|
8.43e-04
|
GO:0009100
|
glycoprotein metabolic process
|
|
1.27
|
8.94e-04
|
GO:0043933
|
macromolecular complex subunit organization
|
|
1.27
|
9.44e-04
|
GO:0042180
|
cellular ketone metabolic process
|
|
1.28
|
9.95e-04
|
GO:0040011
|
locomotion
|
|
1.27
|
1.03e-03
|
GO:0019752
|
carboxylic acid metabolic process
|
|
1.27
|
1.03e-03
|
GO:0043436
|
oxoacid metabolic process
|
|
1.26
|
1.05e-03
|
GO:0070887
|
cellular response to chemical stimulus
|
|
1.29
|
1.15e-03
|
GO:0010647
|
positive regulation of cell communication
|
|
1.60
|
1.20e-03
|
GO:0030324
|
lung development
|
|
1.62
|
1.31e-03
|
GO:0090092
|
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
|
|
1.69
|
1.41e-03
|
GO:0034504
|
protein localization to nucleus
|
|
1.35
|
1.42e-03
|
GO:0009725
|
response to hormone stimulus
|
|
1.66
|
1.43e-03
|
GO:0031346
|
positive regulation of cell projection organization
|
|
1.52
|
1.44e-03
|
GO:0010553
|
negative regulation of gene-specific transcription from RNA polymerase II promoter
|
|
1.34
|
1.44e-03
|
GO:0000278
|
mitotic cell cycle
|
|
1.33
|
1.45e-03
|
GO:0006974
|
response to DNA damage stimulus
|
|
1.36
|
1.49e-03
|
GO:0031401
|
positive regulation of protein modification process
|
|
1.26
|
1.56e-03
|
GO:0006082
|
organic acid metabolic process
|
|
1.16
|
1.59e-03
|
GO:0006950
|
response to stress
|
|
1.37
|
1.60e-03
|
GO:0008283
|
cell proliferation
|
|
1.57
|
1.62e-03
|
GO:0010720
|
positive regulation of cell development
|
|
1.25
|
1.67e-03
|
GO:0022414
|
reproductive process
|
|
1.25
|
1.86e-03
|
GO:0000003
|
reproduction
|
|
1.34
|
1.89e-03
|
GO:0016477
|
cell migration
|
|
1.31
|
2.06e-03
|
GO:0006928
|
cellular component movement
|
|
1.30
|
2.07e-03
|
GO:0030030
|
cell projection organization
|
|
1.63
|
2.28e-03
|
GO:0021915
|
neural tube development
|
|
1.39
|
2.33e-03
|
GO:0048568
|
embryonic organ development
|
|
1.30
|
2.37e-03
|
GO:0051336
|
regulation of hydrolase activity
|
|
1.66
|
2.41e-03
|
GO:0018205
|
peptidyl-lysine modification
|
|
1.45
|
2.56e-03
|
GO:0046578
|
regulation of Ras protein signal transduction
|
|
1.27
|
2.80e-03
|
GO:0065003
|
macromolecular complex assembly
|
|
1.53
|
2.91e-03
|
GO:0042692
|
muscle cell differentiation
|
|
1.30
|
3.12e-03
|
GO:0009967
|
positive regulation of signal transduction
|
|
1.29
|
3.13e-03
|
GO:0009057
|
macromolecule catabolic process
|
|
1.44
|
3.32e-03
|
GO:0010564
|
regulation of cell cycle process
|
|
1.22
|
3.44e-03
|
GO:0042592
|
homeostatic process
|
|
1.62
|
3.74e-03
|
GO:0042176
|
regulation of protein catabolic process
|
|
1.71
|
3.92e-03
|
GO:0042326
|
negative regulation of phosphorylation
|
|
1.31
|
4.04e-03
|
GO:0048666
|
neuron development
|
|
1.41
|
4.20e-03
|
GO:0051056
|
regulation of small GTPase mediated signal transduction
|
|
1.56
|
4.38e-03
|
GO:0046039
|
GTP metabolic process
|
|
1.34
|
4.53e-03
|
GO:0007423
|
sensory organ development
|
|
1.46
|
4.60e-03
|
GO:0033365
|
protein localization to organelle
|
|
1.52
|
4.72e-03
|
GO:0051099
|
positive regulation of binding
|
|
1.50
|
4.91e-03
|
GO:0060537
|
muscle tissue development
|
|
1.41
|
5.07e-03
|
GO:0032880
|
regulation of protein localization
|
|
1.58
|
5.19e-03
|
GO:0006184
|
GTP catabolic process
|
|
1.19
|
5.87e-03
|
GO:0010033
|
response to organic substance
|
|
1.42
|
6.20e-03
|
GO:0048732
|
gland development
|
|
1.48
|
6.36e-03
|
GO:0006605
|
protein targeting
|
|
1.62
|
6.51e-03
|
GO:0017038
|
protein import
|
|
1.51
|
6.62e-03
|
GO:0014706
|
striated muscle tissue development
|
|
1.63
|
6.72e-03
|
GO:0007265
|
Ras protein signal transduction
|
|
1.52
|
7.63e-03
|
GO:0010769
|
regulation of cell morphogenesis involved in differentiation
|
|
1.52
|
7.63e-03
|
GO:0022604
|
regulation of cell morphogenesis
|
|
1.57
|
8.30e-03
|
GO:0045792
|
negative regulation of cell size
|
|
1.53
|
8.75e-03
|
GO:0006417
|
regulation of translation
|
|
1.41
|
9.36e-03
|
GO:0051345
|
positive regulation of hydrolase activity
|
|
1.59
|
9.42e-03
|
GO:0050769
|
positive regulation of neurogenesis
|
|
1.33
|
1.13e-02
|
GO:0007243
|
intracellular protein kinase cascade
|
|
1.33
|
1.13e-02
|
GO:0023014
|
signal transduction via phosphorylation event
|
|
1.70
|
1.16e-02
|
GO:0006473
|
protein acetylation
|
|
1.34
|
1.29e-02
|
GO:0003006
|
developmental process involved in reproduction
|
|
1.31
|
1.45e-02
|
GO:0006066
|
alcohol metabolic process
|
|
1.05
|
1.49e-02
|
GO:0065007
|
biological regulation
|
|
1.25
|
1.58e-02
|
GO:0044255
|
cellular lipid metabolic process
|
|
1.50
|
1.62e-02
|
GO:0009101
|
glycoprotein biosynthetic process
|
|
1.26
|
1.63e-02
|
GO:0030182
|
neuron differentiation
|
|
2.01
|
1.69e-02
|
GO:0048146
|
positive regulation of fibroblast proliferation
|
|
1.48
|
1.69e-02
|
GO:0048545
|
response to steroid hormone stimulus
|
|
1.77
|
1.69e-02
|
GO:0009798
|
axis specification
|
|
1.29
|
1.77e-02
|
GO:0051338
|
regulation of transferase activity
|
|
1.88
|
1.87e-02
|
GO:0060349
|
bone morphogenesis
|
|
1.73
|
1.88e-02
|
GO:0016573
|
histone acetylation
|
|
1.73
|
1.88e-02
|
GO:0034330
|
cell junction organization
|
|
1.72
|
1.92e-02
|
GO:0006475
|
internal protein amino acid acetylation
|
|
1.72
|
1.92e-02
|
GO:0018393
|
internal peptidyl-lysine acetylation
|
|
1.63
|
1.93e-02
|
GO:0045787
|
positive regulation of cell cycle
|
|
1.33
|
1.94e-02
|
GO:0031175
|
neuron projection development
|
|
1.71
|
1.95e-02
|
GO:0048738
|
cardiac muscle tissue development
|
|
1.26
|
1.98e-02
|
GO:0044092
|
negative regulation of molecular function
|
|
1.48
|
1.99e-02
|
GO:0006260
|
DNA replication
|
|
1.29
|
2.03e-02
|
GO:0048870
|
cell motility
|
|
1.29
|
2.03e-02
|
GO:0051674
|
localization of cell
|
|
1.37
|
2.12e-02
|
GO:0003002
|
regionalization
|
|
1.35
|
2.18e-02
|
GO:0012502
|
induction of programmed cell death
|
|
1.28
|
2.18e-02
|
GO:0070271
|
protein complex biogenesis
|
|
1.84
|
2.27e-02
|
GO:0048145
|
regulation of fibroblast proliferation
|
|
1.28
|
2.33e-02
|
GO:0006461
|
protein complex assembly
|
|
1.29
|
2.33e-02
|
GO:0044265
|
cellular macromolecule catabolic process
|
|
1.56
|
2.33e-02
|
GO:0030308
|
negative regulation of cell growth
|
|
1.94
|
2.44e-02
|
GO:0042733
|
embryonic digit morphogenesis
|
|
1.28
|
2.63e-02
|
GO:0071822
|
protein complex subunit organization
|
|
1.53
|
2.75e-02
|
GO:0010638
|
positive regulation of organelle organization
|
|
1.77
|
2.91e-02
|
GO:0014020
|
primary neural tube formation
|
|
1.35
|
2.98e-02
|
GO:0006917
|
induction of apoptosis
|
|
1.47
|
2.99e-02
|
GO:0001655
|
urogenital system development
|
|
1.63
|
3.25e-02
|
GO:0035148
|
tube formation
|
|
1.72
|
3.29e-02
|
GO:0009411
|
response to UV
|
|
1.31
|
3.32e-02
|
GO:0008610
|
lipid biosynthetic process
|
|
1.71
|
3.34e-02
|
GO:0006606
|
protein import into nucleus
|
|
1.70
|
3.38e-02
|
GO:0018394
|
peptidyl-lysine acetylation
|
|
1.70
|
3.38e-02
|
GO:0051170
|
nuclear import
|
|
1.05
|
3.41e-02
|
GO:0050789
|
regulation of biological process
|
|
1.55
|
3.70e-02
|
GO:0021537
|
telencephalon development
|
|
1.36
|
3.83e-02
|
GO:0048812
|
neuron projection morphogenesis
|
|
1.96
|
4.09e-02
|
GO:0045216
|
cell-cell junction organization
|
|
1.46
|
4.22e-02
|
GO:0045926
|
negative regulation of growth
|
